Clinical Trials Browser

Phase 1 × Multiple Myeloma × Maximum Tolerated Dose × Clear all

NCT05976555 2025-06-11

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Phase 1 Not yet recruiting

Multiple Myeloma